Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroid + Hyaluronic Acid vs Corticosteroid Alone in Supraspinatus Tendinopathy
NCT06376981Phase 3Recruiting
- Sponsor
- CHD Vendée
- Start
- Sep 2024
- Primary completion
- Dec 2026
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of hyaluronic acid in supraspinatus tendinopathy, sponsored by CHD Vendée. Started Sep 2024; status: recruiting.
02
Drugs
hyaluronic acid
03
Conditions
supraspinatus tendinopathy
Beyond the preview
Go deeper on NCT06376981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06376981.